EXENATIDE LEADS TO REDUCTION IN LIVER ENZYMES IN DIABETICS INDEPENDENT OF WEIGHT LOSS

Links shared publicly online about this topic.

1,195
total visits

EXENATIDE LEADS TO REDUCTION IN LIVER ENZYMES IN DIABETICS INDEPENDENT OF WEIGHT LOSS

I just got back from the AACE Annual sessions in Orlando. It was great to see a lot of you and appreciated the nice comments you had about our newsletter. I did not have a lot of time to put together an overview for out deadline but did want to share an abstract of interest. Deepti Bulchandani, MD and his colleagues have looked at Exenatide for the treatment of elevated enzymes in Non alcoholic fatty liver disease. This is another possible reason to start your patients on Exenatide. Click here t

View full resource at diabetesincontrol.com

Tags: Liver, Liver Condition, Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Weight Loss, Alcoholic, Byetta